chr12-53160172-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001244705.2(CSAD):āc.1114C>Gā(p.Gln372Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,614,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001244705.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSAD | NM_001244705.2 | c.1114C>G | p.Gln372Glu | missense_variant | 14/17 | ENST00000444623.6 | NP_001231634.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSAD | ENST00000444623.6 | c.1114C>G | p.Gln372Glu | missense_variant | 14/17 | 1 | NM_001244705.2 | ENSP00000415485.1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251226Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135806
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461740Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727174
GnomAD4 genome AF: 0.000158 AC: 24AN: 152358Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 03, 2024 | The c.1195C>G (p.Q399E) alteration is located in exon 14 (coding exon 13) of the CSAD gene. This alteration results from a C to G substitution at nucleotide position 1195, causing the glutamine (Q) at amino acid position 399 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at